Cochrane works collaboratively with partners and funders to produce and disseminate authoritative, relevant, and reliable health evidence. Our funding and partner relationships reflect our commitment to help improve the world's health through high quality, up-to-date research evidence, and to make this information accessible and easy to understand.
Independent and transparent
In 2020, Cochrane's central organizational income was £13 million GBP (2019: £8 million GBP). Much of this income is derived from the proceeds of the Cochrane Library and other Cochrane products and also includes commercial enhancements related to the new publishing contract with Wiley. This income is invested back into the organization by our Governing Board to deliver the goals of our organizational strategy. You can find a full account of Cochrane’s central organization’s income and expenditure in its official Trustees Report, Financial Statements and Annual Review, here.
Our global network of Groups is supported by national governments, international governmental and non-governmental organizations, universities, hospitals, private foundations, and personal donations worldwide. The direct income in 2019 for Cochrane Groups was about £16 million GBP (see below for more details).
Cochrane is able to generate authoritative and reliable information because we never accept commercial or conflicted funding. This policy means Cochrane contributors can work freely, unconstrained by commercial or financial interests.
Read more about our policy on commercial sponsorship.
Our funders
We do not accept commercial or conflicted funding – this is vital for us to generate authoritative and reliable information, produced by people who can work freely, unconstrained by commercial and financial interests.
Cochrane wishes to thank the following organizations for their support in 2019:
More than £1 million
National Institute for Health and Care Research (NIHR)
The National Institute for Health and Care Research (NIHR) (UK) is the research arm of the NHS and is funded through the Department of Health and Social Care to improve the health and wealth of the nation through research. It is a large, multi-faceted and nationally distributed organization. Together, NIHR people, facilities and systems represent the most integrated clinical research system in the world. NIHR is the largest single funder of Cochrane, and currently supports 21 Cochrane Review Groups based in England.
Den danske regering/The Danish Government (Rigshospitalet Research Committee)
Den danske regering/The Danish Government (Rigshospitalet Research Committee) (Denmark) are a highly specialised hospital which, with a few exceptions, covers all medical specialist areas.
£500K to 1 million
Bundesministerium für Gesundheit (BMG) - Federal Ministry of Health
The Federal Ministry of Health (Germany) is responsible for a variety of policy areas, whereby its activities focus predominantly on the drafting of bills, ordinances and administrative regulations. Moreover, by means of prevention campaigns, the Federal Ministry of Health seeks to improve the population's health.
National Institutes of Health (NIH)
The National Institutes of Health (NIH) (USA), a part of the U.S. Department of Health and Human Services, is the nation's medical research agency - making important discoveries that improve health and save lives.
More than 1 million GBP
National Institute for Health Research (UK)
Danish Health Authorities (Denmark)
500k to 1 million GBP
Federal Ministry of Health (Germany)
National Health and Medical Research Council (Australia)
National Institutes of Health (USA)
Health Research Board (Ireland) / Public Health Agency, Health and Social Care Research and Development (Northern Ireland)
South African Medical Research Council (South Africa)
Cochrane Charity (central funds awarded within the collaboration)
World Health Organization
100k to 500k GBP
Foreign, Commonwealth and Development Office (UK)
Direction générale de l’offre de soins (France)
Ministry of Health, Social Services and Equality (Spain)
Chief Scientist Office (Scotland)
Ministry of Health (New Zealand)
Ministry of Health, British Columbia (Canada)
McMaster University (Canada)
Norwegian Agency for Development Cooperation (Norway)
Health and Social Fund, Lower Austria (Austria)
Amsterdam University Medical Center (Netherlands)
Institut National du Cancer (France)
Ministry of Health (Austria)
50k to 100k GBP
Zorginstituut (Netherlands)
Ministry of Health (Brazil)
Public Health England - Delivering Better Oral Health
Government of Brazil
Swiss Medical Board (Switzerland)
Vermont Oxford Network (USA)
European Commission
Department of Health (South Africa)
National Research Foundation (South Africa)
Federal Ministry of Education and Research (South Africa)
Canada Research Chair Critical Care Neurology and Trauma (Canada)
Skåne University Hospital (Sweden)
20k to 50k GBP
Ministry of Health and Welfare (Taiwan)
American Heart Association (USA)
Liverpool School of Tropical Medicine (UK)
Laura & John Arnold Foundation (USA)
Lund University (Sweden)
Canadian Institutes of Health Research (Canada)
Gerber Foundation (USA)
CIBER de Epidemiología y Salud Pública (Spain)
Cochrane Oral Health Global Alliance
University of Ottawa (Canada)
Cochrane Japan
University of Auckland (New Zealand)
Odense University Hospital (Denmark)
Canadian Rheumatology Association (Canada)
Società Italiana di Cure Palliative (Italy)
Cochrane UK
Health Authority, Umbria Region (Italy)
State of Lower Austria (Austria)
Faculdade de Medicina de Lisboa (Portugal)
European Academy for Neurology
University of Pécs (Hungary)
10k to 20k GBP
Royal Society Te Apārangi (New Zealand)
Lower Austrian Health and Social Fund (Austria)
Singapore Clinical Research Institute (SCRI)
Associazione Italiana Dislessia (Italy)
Netherlands Trial Register (Netherlands)
Population Health Research Institute (Canada)
Stichting Collège Européen de Médecine physique et de Réadaptation
Bundesamt für Gesundheit (Switzerland)
Kazan Federal University (Russia)
National Institute for Health and Care Excellence (UK)
Canadian Association of Gastroenterology (Canada)
Centre Hospitalier Universitaire de Québec-Université Laval (Canada)
Istituto Superiore di Sanità (Italy)
Safer Care Victoria (Australia)
American College of Gastroenterology (USA)
Tees, Esk and Wear Valleys NHS Foundation Trust (UK)
Department of Health (Australia)
International Parkinson and Movement Disorder Society
0.5k to 10k GBP
Korea University (South Korea)
Research England (UK)
Brazilian Society of Rheumatology (Brazil)
La Trobe University (Australia)
Spanish Society of Pneumology and Thoracic Surgery (Spain)
European Respiratory Society
Spanish Breast Cancer Research Group (Spain)
International Society of Physical and Rehabilitation Medicine
Cochrane Deutschland Stiftung (Germany)
Region Skåne (Sweden)
University of Copenhagen (Denmark)
National Institute for Medical Research Development (Iran)
American Academy of Pediatrics (USA)
Brazilian College of Radiology and Diagnostic Imaging (Brazil)
Québec SPOR Support Unit (Canada)
University of Oxford (UK)
Swisstransplant (Switzerland)
Ministry of Health (Chile)
Sant Pau Institute for Biomedical Research (Spain)
Agency for Health Quality and Assessment of Catalonia (Spain)
Burnet Institute (Australia)
Stellenbosch University (South Africa)
Patientforening Danmark (Denmark)
Jagiellonian University Medical College (Poland)
Universitat Autonoma de Barcelona (Spain)
City of Zagreb (Croatia)
Anonymous donations: compliant with Conflict of Interest policy
University of Split (Croatia)
Audrey Campbell Ulcerative Colitis Chair (Canada)
RCSI & UCD Malaysia Campus (Malaysia)
University of York (UK)
Universidad de Valparaiso (Chile)
Motor Neurone Disease Association (UK)
Istituto Jemelo (Italy)
Fudan University (China)
City of Split (Croatia)
Cochrane Australia (Australia)
Capital Region of Denmark (Denmark)
University of Otago (New Zealand)
University of Guadalajara (Mexico)
Monash University (Australia)
Less than 500 GBP
National Institute for Occupational Health (South Africa)
John Wiley & Sons, Ltd
Departamento Administrativo del Servicio Civil Distrital, Alcaldía Mayor de Bogotá (Colombia)
Our partners
We work collaboratively with partners to produce and disseminate authoritative, relevant, and reliable health evidence. Our partner relationships reflect our commitment to help improve the world's health through high quality, up-to-date research evidence, and to make this information accessible and easy to understand.
Cochrane wishes to thank the following partners for their support:
AllTrials
The AllTrials campaign calls for all past and present clinical trials to be registered and their results reported. Hundreds of thousands of clinical trials have been conducted from which no or limited data have been made available; data critical to enabling doctors and regulators to make informed decisions about which treatments to use and fund. AllTrials founders were Ben Goldacre, author of Bad Science, along with the charity Sense About Science; the Centre for Evidence Based Medicine in Oxford; the James Lind Initiative; the BMJ ; and Cochrane.
Campbell Collaboration
The Campbell Collaboration is an international research network that produces and disseminates systematic reviews on the effects of interventions in the social and behavioural sciences. It seeks to improve the quality of public and private services through enhancing the evidence base for social policy and practice. It produces reviews in the areas of Crime and Justice, Education, International Development, and Social Welfare. Cochrane and Campbell have been closely affiliated since Campbell's establishment in 2000. In 2015 the two collaborations are formalizing plans to work more cooperatively and effectively together in a number of areas of common interest.
Evidence Aid
Evidence Aid started as a project within Cochrane, and was subsequently registered as an independent charity in 2015. Evidence Aid’s vision is that those in need receive humanitarian aid in the most timely, effective and appropriate way possible. To achieve this, Evidence Aid’s mission is to inspire and enable those guiding the humanitarian sector to apply an evidence-based approach in their activities and decisions. In doing this, Evidence Aid raises the profile of systematic reviews, including those published in the Cochrane Library, within the humanitarian sector.
Guidelines International Network
Guidelines International Network's (GIN) mission is to lead, strengthen, and support collaboration in guideline development, adaptation and implementation. Cochrane and GIN formalized a partnership arrangement in 2014, agreeing to work together collaboratively to ensure that evidence is both useful and used by people making decisions about health, from individuals to clinicians to international health policy-makers from all over the world.
Wikipedia
Articles relating to medicine are viewed more than 180 million times per month on Wikipedia, yet less than 1 per cent of these have passed a formal peer review process. This opens up a unique opportunity for Cochrane to work with Wikipedia medical editors to transform the quality and content of health evidence available online. The partnership, formalized in 2014, supports the inclusion of relevant evidence within all Wikipedia medical articles, as well as processes to help ensure that medical information included in Wikipedia is of the highest quality and as accurate as possible. Trusted, evidence-based research can help people to make informed decisions about their own health care.
Wiley
John Wiley & Sons ( Wiley) has been Cochrane's principal publishing partner since 2003, working closely with Cochrane contributors and staff to support publication of the Cochrane Library on Wiley's internationally recognized electronic publishing platform. Over the course of the Cochrane-Wiley partnership, more than half the world's population has secured one-click access to Cochrane content through licenses or free access programmes.
World Health Organization
Cochrane has been in official relations with the World Health Organization (WHO) since 2011. This collaboration includes the right to appoint a representative to participate, without vote, in WHO's meetings, including at the World Health Assembly, the WHO's decision-making body, allowing us to make expository statements on WHO health resolutions. This relationship gives us the opportunity to provide input on the way research evidence is identified, synthesized, assessed and used by WHO. In addition, we provide reliable summaries of health information which can be used to inform recommendations and policies. It promotes intersectoral collaboration and high-quality research between our two organizations to produce the necessary evidence to ensure policies in all sectors contribute to improving health and health equity.
Contact us if you would like to know more about how to become a partner of Cochrane.